ArticleNPJ digital medicine2026
Combining federated learning and travelling model boosts performance and opens opportunities for digital health equity.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial Intelligence in Neuromuscular Diseases: Opportunities for a Data-Scarce Field.Neurology and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Federated learning (FL) and travelling model (TM) allow privacy-preserving model training across sites without sharing patient-sensitive data. While both approaches have shown success, they face unique challenges related to distribution shifts between sites. To address this, we propose FedTM, a hybrid framework combining the strengths of FL and TM. FedTM begins with FL warmup training at sites with larger datasets, followed by sequential refinement through TM across all sites. We evaluated FedTM for Parkinson's disease classification using 1817 brain scans from 83 international sites. Model performance, misclassification disparities, and communication costs were computed and compared to standard FL and TM approaches. Our results reveal that FedTM improves AUROC from 77 ± 0.01% to 82 ± 0.01%, reduces misclassification disparities from 34 ± 0.01% to 26 ± 0.01%, and decreases training load for smaller sites from 22 to 12 cycles. These advancements mark an important step toward promoting global healthcare equity and advancing responsible AI development.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.